European Medical Solutions (EBR:ALEMS)
4.750
+0.250 (5.54%)
Oct 9, 2025, 4:45 PM CET
EBR:ALEMS Revenue
European Medical Solutions had revenue of 24.76M EUR in the half year ending June 30, 2025, with 13.60% growth. This brings the company's revenue in the last twelve months to 49.47M, up 12.63% year-over-year. In the year 2024, European Medical Solutions had annual revenue of 47.91M with 12.67% growth.
Revenue (ttm)
49.47M
Revenue Growth
+12.63%
P/S Ratio
0.41
Revenue / Employee
405.52K
Employees
122
Market Cap
20.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 47.91M | 5.39M | 12.67% |
Dec 31, 2023 | 42.53M | 5.47M | 14.76% |
Dec 31, 2022 | 37.06M | -963.00K | -2.53% |
Dec 31, 2021 | 38.02M | 37.66M | 10,491.90% |
Dec 31, 2020 | 358.94K | -705.90K | -66.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.85B |
argenx SE | 2.66B |
Financière de Tubize | 13.26K |
Fagron NV | 918.75M |
Ion Beam Applications | 585.76M |
Onward Medical | 2.72M |
Nyxoah | 4.93M |
Hyloris Pharmaceuticals | 8.46M |